# Pranav Gandhi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pranav-gandhi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 926 |
| Field | Migraine and Headache Studies |
| h-index | 18 |
| i10-index | 27 |
| Last Known Institution | AbbVie (United States) |
| OpenAlex ID | https://openalex.org/A5036025969 |
| ORCID iD | 0009-0008-8317-7712 |
| Works | 87 |

## Researcher papers

- [Digital Whole Slide Imaging Compared With Light Microscopy for Primary Diagnosis in Surgical Pathology](https://scholariq.org/papers/digital-whole-slide-imaging-compared-with-light-microscopy-for-primary-diagnosis/)
- [Exploring factors influencing asthma control and asthma-specific health-related quality of life among children](https://scholariq.org/papers/exploring-factors-influencing-asthma-control-and-asthma-specific-health-related/)
- [Thrombotic Events Associated with C1 Esterase Inhibitor Products in Patients with Hereditary Angioedema: Investigation from the United States Food and Drug Administration Adverse Event Reporting System Database](https://scholariq.org/papers/thrombotic-events-associated-with-c1-esterase-inhibitor-products-in-patients/)
- [The Relationships Between Fatigue, Quality of Life, and Family Impact Among Children With Special Health Care Needs](https://scholariq.org/papers/the-relationships-between-fatigue-quality-of-life-and-family-impact-among/)
- [Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease](https://scholariq.org/papers/cost-effectiveness-analysis-of-empagliflozin-in-comparison-to-sitagliptin-and/)
- [Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial](https://scholariq.org/papers/efficacy-of-atogepant-in-chronic-migraine-with-and-without-acute-medication/)
- [Assessment of response shift using two structural equation modeling techniques](https://scholariq.org/papers/assessment-of-response-shift-using-two-structural-equation-modeling-techniques/)
- [Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial](https://scholariq.org/papers/effect-of-atogepant-for-preventive-migraine-treatment-on-patient-reported/)
- [Cost-Effectiveness Analysis of Allopurinol Versus Febuxostat in Chronic Gout Patients: A U.S. Payer Perspective](https://scholariq.org/papers/cost-effectiveness-analysis-of-allopurinol-versus-febuxostat-in-chronic-gout/)
- [Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease](https://scholariq.org/papers/cost-effectiveness-of-empagliflozin-versus-canagliflozin-dapagliflozin-or/)
- [Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States](https://scholariq.org/papers/impact-of-headache-frequency-and-preventive-treatment-failure-on-quality-of-life/)

## Researcher topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Traumatic Brain Injury Research](https://scholariq.org/topics/traumatic-brain-injury-research/)
- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [AbbVie (United States)](https://scholariq.org/institutions/abbvie-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.